Medtronic beat estimates this week with “solid” performance in all of its businesses and markets, said CEO Omar Ishrak, which puts the company back on track after reported Q2 slowdown last year.
Philips aims to meet the needs of growing economic uncertainty and rapidly advancing digital health market with a high-performance, scalable health informatics platform featuring an end-to-end managed service and risk-sharing pay-per-use model, according to senior executives.
The Juvenile Diabetes Research Fund (JDRF) has invested in a long-lasting continuous glucose monitor (CGM) that uses engineered live cells to replenish and maintain the stability of the implant’s optical biosensor over time.
FlowAid Medical Technologies (FlowAid), makers of non-invasive devices and therapies for circulatory disorders affecting extremities, have announced FDA approval for a calf muscle stimulation system that reduces incidence of blood clots and swelling.
Hologic, a manufacturer of diagnostics and women's health products, is moving into the burgeoning — but still underpenetrated — $2 billion medical aesthetics market by acquiring Cynosure, a leading maker of non-invasive body contouring, hair removal, and skin revitalization products.
Siemens Healthineers announced FDA approval for its new 1.5 Tesla MRI system, which uses an algorithm to decrease acquisition times, meaning the system experiences less motion interference and is less likely to require a rescan.
Moves under consideration include separation of medtech from its pharmaceutical industry, increased government funding for the medtech industry, and the renegotiation of existing free trade agreements (FTAs) with other countries. The device industry also is asking the government to recognize local regulatory certifications, in addition to the currently accepted FDA approval from the U.S.
Harvard scientists are testing a neural prosthesis that uses arrays of microscopic coils to generate magnetic fields that can target specific regions of the brain, such as the visual cortex to simulate sight.
Abbott has announced that the FDA approved MR-conditional labeling for its Assurity pacemaker, touted by the company as the “world’s smallest and longest-lasting” MRI-compatible wireless pacemaker.
The U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced that it will move forward with its proposal to increase and/or add fees charged to medical device makers applying for regulatory approval for designations, audits, registrations, and clinical investigations. The fees are intended to offset regulatory costs, and will undergo regular audits to ensure they remain fair.